Aim: Neoadjuvant chemotherapy is used to increase tumor resection rates, prevent metastasis and prolong survival. It is not fully understood which factors are important in recurrence after surgery. In our study, the effects of neoadjuvant chemotherapy treatment duration, tumor histopathology, and biochemical values on postoperative recurrence in gastric cancer patients were investigated. Method: Our study included 61 patients who were diagnosed with locally advanced gastric cancer and underwent surgery after neoadjuvant chemotherapy. The duration of treatment with neoadjuvant, the number of pathological lymph nodes removed during surgery, preoperative albumin level, and postoperative carcinoembryonic antigen (CEA) values were compared and evaluated according to the recurrence status. Results: The mean age of our patients was 58.70±10.58 years. In patients who developed recurrence after surgery, the number of pathological lymph nodes removed during surgery and the postoperative CEA value was found to be statistically significantly higher (p <0.001, p=0.005, respectively), and high preoperative albumin levels reduced recurrence (HR=0.016). Conclusion: In our study, it was shown that preoperative albumin level and postoperative CEA value were associated with the development of recurrence after surgery in gastric cancer patients receiving neoadjuvant therapy.
Amaç: Neoadjuvan kemoterapi, tümör rezeksiyon oranlarını arttırmak, metastazı önlemek ve sağkalımı uzatmak amacıyla kullanılmaktadır. Cerrahi sonrası nükste hangi faktörlerin önemli olduğu tam olarak anlaşılamamıştır. Çalışmamızda mide kanseri hastalarında neoadjuvan kemoterapi tedavi süresi, tümör histopatolojisi ve biyokimyasal değerlerin cerrahi sonrası nüks üzerindeki etkisi araştırılmıştır. Yöntem: Çalışmamıza lokal ileri evre mide kanseri tanısı olan, neoadjuvan kemoterapi sonrası cerrahi uygulanan 61 hasta dahil edildi. Hastaların neoadjuvan ile tedavi süresi, cerrahide çıkarılan patolojik lenf nodu sayısı, preoperatif albümin seviyesi, postoperatif karsiyoembriyonik antijen (CEA) değerleri karşılaştırılıp, nüks durumuna göre değerlendirildi. Bulgular: Hastalarımızın yaş ortalaması 58.70±10.58’dir. Cerrahi sonrası nüks gelişen hastalarda cerrahide çıkarılan patolojik lenf nodu sayısının ve postoperatif CEA değerinin istatistiksel olarak önemli düzeyde daha fazla olduğu (sırasıyla p <0.001, p=0.005), preoperatif albümin seviyesinin yüksekliğinin nüksü azalttığı (HR=0.016) bulunmuştur. Sonuç: Çalışmamızda neoadjuvan tedavi alan mide kanseri hastalarında, preoperatif albümin seviyesi ve postoperatif CEA değerinin cerrahi sonrası nüks gelişimi ile ilişkili olduğu gösterilmiştir.
Primary Language | Turkish |
---|---|
Subjects | Health Care Administration |
Journal Section | Articles |
Authors | |
Early Pub Date | August 1, 2023 |
Publication Date | August 17, 2023 |
Submission Date | March 31, 2023 |
Acceptance Date | June 9, 2023 |
Published in Issue | Year 2023 Volume: 16 Issue: 2 |
MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.
Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.
Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.
Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.
Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.
Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.
This work is licensed with Attribution-NonCommercial 4.0 International.